• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在肯尼亚西南部,食管癌患者亲属中食管鳞状上皮异型增生的流行情况。

Prevalence of esophageal squamous dysplasia in relatives of patients with esophageal cancer in Southwestern Kenya.

机构信息

Department of Surgery and Endoscopy, Tenwek Hospital, Bomet, Kenya.

Department of Surgery and Endoscopy, Tenwek Hospital, Bomet, Kenya.

出版信息

Cancer Epidemiol. 2022 Jun;78:102141. doi: 10.1016/j.canep.2022.102141. Epub 2022 Mar 15.

DOI:10.1016/j.canep.2022.102141
PMID:35299153
Abstract

BACKGROUND

Esophageal squamous cell carcinoma (ESCC) and its asymptomatic precursor lesion, esophageal squamous dysplasia (ESD), are common in East Africa. It is unknown whether family history of esophageal cancer is a risk factor for both ESD and ESCC in Africa, and whether family members of affected persons should be screened.

METHODS

We recruited 296 asymptomatic adult first-degree relatives of ESCC patients residing in southwestern Kenya. Participants completed questionnaires and underwent endoscopy with Lugol's iodine staining and biopsy to determine the prevalence of ESD. Prevalence comparisons were made with a prior population-based cohort from the same catchment area who also underwent Lugol's chromoendoscopy.

RESULTS

Mean age was 40.7 years, compared to 62.7 years in the prior population study. The overall prevalence of ESD/ESCC among first-degree relatives was 14.7%, comparable to the background population prevalence of 14.4%, and this comparability remained even after adjusting for the different age distributions of the studies. Post-primary education was the only measured variable that was associated with a decreased risk of ESD/ESCC (adjusted OR=0.31, 95% CI: 0.11, 0.83). There was heterogeneity in the ESD prevalence across families, even after adjustments for varying age and other measured factors.

CONCLUSIONS

The prevalence of esophageal squamous dysplasia among first-degree relatives of persons with ESCC was similar to that of the background population of southwestern Kenya; however, there was heterogeneity in ESD prevalence between families, suggesting other genetic or environmental factors may influence family prevalence. Further study of families with a high prevalence of ESD or ESCC is justified.

摘要

背景

食管鳞状细胞癌(ESCC)及其无症状前体病变食管鳞状上皮不典型增生(ESD)在东非很常见。目前尚不清楚食管癌家族史是否是非洲 ESD 和 ESCC 的危险因素,以及受影响者的家庭成员是否应该进行筛查。

方法

我们招募了 296 名居住在肯尼亚西南部的 ESCC 患者的无症状一级亲属。参与者完成了问卷调查,并接受了卢戈氏碘染色和活组织检查的内镜检查,以确定 ESD 的患病率。与来自同一集水区的先前基于人群的队列进行患病率比较,该队列也接受了卢戈氏染色内镜检查。

结果

平均年龄为 40.7 岁,而先前的人群研究为 62.7 岁。一级亲属中 ESD/ESCC 的总体患病率为 14.7%,与背景人群的患病率 14.4%相当,即使在调整了两项研究的不同年龄分布后,这种可比性仍然存在。接受过中学后教育是唯一与 ESD/ESCC 风险降低相关的测量变量(调整后的 OR=0.31,95%CI:0.11,0.83)。即使在调整了年龄和其他测量因素的差异后,家族间 ESD 的患病率仍然存在异质性。

结论

ESCC 患者一级亲属的食管鳞状上皮不典型增生患病率与肯尼亚西南部背景人群相似;然而,家族间 ESD 患病率存在异质性,提示其他遗传或环境因素可能影响家族患病率。有必要对 ESD 或 ESCC 患病率较高的家族进行进一步研究。

相似文献

1
Prevalence of esophageal squamous dysplasia in relatives of patients with esophageal cancer in Southwestern Kenya.在肯尼亚西南部,食管癌患者亲属中食管鳞状上皮异型增生的流行情况。
Cancer Epidemiol. 2022 Jun;78:102141. doi: 10.1016/j.canep.2022.102141. Epub 2022 Mar 15.
2
Esophageal Squamous Dysplasia is Common in Asymptomatic Kenyans: A Prospective, Community-Based, Cross-Sectional Study.食管鳞状发育异常在无症状的肯尼亚人中很常见:一项基于社区的前瞻性横断面研究。
Am J Gastroenterol. 2016 Apr;111(4):500-7. doi: 10.1038/ajg.2016.26. Epub 2016 Feb 23.
3
Cross sectional study of serum selenium concentration and esophageal squamous dysplasia in western Kenya.肯尼亚西部血清硒浓度与食管鳞状上皮发育异常的横断面研究。
BMC Cancer. 2017 Dec 8;17(1):835. doi: 10.1186/s12885-017-3837-9.
4
Indoor wood combustion, carcinogenic exposure and esophageal cancer in southwest Kenya.室内木材燃烧、致癌暴露与肯尼亚西南部的食管癌。
Environ Int. 2021 Jul;152:106485. doi: 10.1016/j.envint.2021.106485. Epub 2021 Mar 6.
5
Pre-procedure oral administration of pronase improves efficacy of lugol chromoendoscopy in esophageal squamous cell carcinoma screening: a prospective, double-blinded, randomized, controlled trial.术前口服糜蛋白酶提高卢戈氏碘染色内镜筛查食管鳞癌的效果:一项前瞻性、双盲、随机、对照临床试验。
Surg Endosc. 2023 Jun;37(6):4421-4430. doi: 10.1007/s00464-023-09902-1. Epub 2023 Feb 13.
6
Increased risk of esophageal squamous cell carcinoma in patients with squamous dysplasia: a nationwide cohort study in the Netherlands.食管鳞状细胞癌风险增加:荷兰全国队列研究中鳞状上皮发育不良患者。
Dis Esophagus. 2023 Nov 30;36(12). doi: 10.1093/dote/doad045.
7
Screening for dysplasia with Lugol chromoendoscopy in longstanding idiopathic achalasia.Lugol 染色内镜筛查特发性贲门失弛缓症的长期不典型增生。
Am J Gastroenterol. 2018 Jun;113(6):855-862. doi: 10.1038/s41395-018-0064-1.
8
Alcohol consumption and oesophageal squamous cell cancer risk in east Africa: findings from the large multicentre ESCCAPE case-control study in Kenya, Tanzania, and Malawi.饮酒与东非食管鳞状细胞癌风险:来自肯尼亚、坦桑尼亚和马拉维大型多中心 ESCCAPE 病例对照研究的结果。
Lancet Glob Health. 2022 Feb;10(2):e236-e245. doi: 10.1016/S2214-109X(21)00506-4. Epub 2021 Dec 15.
9
Measuring telomere length for the early detection of precursor lesions of esophageal squamous cell carcinoma.检测端粒长度以早期发现食管鳞状细胞癌前病变。
BMC Cancer. 2013 Dec 5;13:578. doi: 10.1186/1471-2407-13-578.
10
Geophagia and risk of squamous cell esophageal cancer in the African esophageal cancer corridor: Findings from the ESCCAPE multicountry case-control studies.食土癖与非洲食管癌高发走廊中食管鳞状细胞癌风险:ESCCAPE 多国病例对照研究的结果。
Int J Cancer. 2021 Sep 15;149(6):1274-1283. doi: 10.1002/ijc.33688. Epub 2021 May 28.

引用本文的文献

1
Characteristics of Esophageal Cancer Among Malawi Natives at a Rural Hospital.一家乡村医院中马拉维当地人食管癌的特征
Cureus. 2025 Mar 18;17(3):e80786. doi: 10.7759/cureus.80786. eCollection 2025 Mar.
2
Landscape of esophageal cancer in Northern Kenya: experience from Garissa Regional Cancer Center.肯尼亚北部食管癌概况:加里萨地区癌症中心的经验
Ecancermedicalscience. 2024 Apr 11;18:1694. doi: 10.3332/ecancer.2024.1694. eCollection 2024.
3
Application of Amiodarone and Cedilan in the Treatment of Patients with Arrhythmia after Esophageal and Lung Cancer.
胺碘酮与西地兰在食管癌和肺癌术后心律失常患者治疗中的应用
Evid Based Complement Alternat Med. 2023 Apr 13;2023:8026918. doi: 10.1155/2023/8026918. eCollection 2023.